Pfizer Recalls 1 Million Packets of Birth Control Pills

WEDNESDAY, Feb. 1 (HealthDay News) — About one million packets
of birth control pills are being recalled in the United States by Pfizer
Inc. because of a packaging error that could reduce the effectiveness of
the pills and cause unintended pregnancies.

The recall of 14 lots of Lo/Ovral-28 tablets and 14 lots of generic
Norgestrel and Ethinyl Estradiol tablets was announced late Tuesday after
Pfizer discovered that some blister packs may contain either too many or
too few active pills and that the pills may be out of sequence. The
expiration dates on the recalled packets range between July 31, 2013 and
March 31, 2014.

The pills are packaged in blister packs containing 21 active tablets
and seven inactive tablets. The packaging error means that the daily
regimen for the pills may be incorrect and could leave women without
adequate contraception and at risk for unintended pregnancy, Pfizer said
in a news release.

Experts said the error could pose real problems for women using the
pills.

“This is extremely important,” said Dr. Steven Goldstein, professor of
obstetrics and gynecology at NYU Langone School of Medicine in New York
City. “It is absolutely essential that birth control pills be taken as
intended, with 21 medicated pills in a row. Otherwise ovulation could
take place and an unintended pregnancy is definitely a
possibility.”

Another expert agreed.

“Sequence and content of active versus inactive pills is crucial in
determining efficacy, including whether or not unwanted pregnancy will be
actually prevented,” said Dr. Jill Rabin, chief of ambulatory care,
obstetrics and gynecology, head of urogynecology at Long Island Jewish
Medical Center in New Hyde Park, N.Y.

She said that women who determine that they do have the recalled
contraceptive pills should first “ensure that you are not currently
pregnant (by taking a pregnancy test) if you have any symptoms of
pregnancy (missed periods/abnormal bleeding, etc).” They should also
switch immediately to a non-hormonal form of contraception if they are not
pregnant, notify their health care provider of the situation, and return
the defective product to the pharmacy.

Pfizer has informed the U.S. Food and Drug Administration about the
recall. In a statement issued Wednesday, the FDA agreed that “patients
who have the affected product should notify their physician and return the
product to the pharmacy.”

The cause of the error was identified and corrected immediately,
according to Pfizer.

The birth control pills were manufactured and packaged by Pfizer and
sold under the Akrimax Pharmaceuticals brand. The pills were distributed
to warehouses, clinics and retail pharmacies across the United States.

More information

Here’s where you can find more details on lot
numbers and other information on pills included in the recall
.

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes